Immediate Impact

1 from Science/Nature 63 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
2023 Standout
4 intermediate papers

Works of Sandra Beare being referenced

Phase I trial of sequential topotecan followed by etoposide in adults with myeloid leukemia: a National Cancer Institute of Canada Clinical Trials Group Study
1999
Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.
1998

Author Peers

Author Last Decade Papers Cites
Sandra Beare 199 109 168 11 368
Angela Bowman 117 67 116 16 402
J. Provençal 143 74 74 10 355
S.B. Kaye 258 145 53 13 406
D E Austin 108 99 105 12 398
Lihui Han 114 55 113 19 381
R. Biamonte 179 103 128 8 353
Jing-Xian Shen 147 91 115 12 372
Irene Grimani 166 81 44 11 357
Yukitoshi AOKI 139 77 50 12 377
Andrew Wiechert 135 151 66 13 381

All Works

Loading papers...

Rankless by CCL
2026